Cargando…

Argatroban for anticoagulation of a blood salvage system - an ex-vivo study

BACKGROUND: Blood salvage systems help to minimize intraoperative transfusion of allogenic blood. So far no data is available on the use of argatroban for anticoagulation of such systems. We conducted an ex-vivo trial to evaluate the effectiveness of three different argatroban doses as compared to h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beiderlinden, Martin, Brau, Carsten, di Grazia, Santo, Wehmeier, Michael, Treschan, Tanja A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946229/ https://www.ncbi.nlm.nih.gov/pubmed/27418211 http://dx.doi.org/10.1186/s12871-016-0204-3

Ejemplares similares

Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry – a prospectively controlled randomized double-blind clinical trial
por: Beiderlinden, Martin, et al.
Publicado: (2018)

Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial
por: Treschan, Tanja A, et al.
Publicado: (2014)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
por: Agarwal, Shvetank, et al.
Publicado: (2012)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
por: Bredthauer, Andre, et al.
Publicado: (2020)

Electrical impedance tomography during major open upper abdominal surgery: a pilot-study
por: Schaefer, Maximilian S, et al.
Publicado: (2014)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting
por: Klingele, Matthias, et al.
Publicado: (2020)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
por: Ma, Hongrui, et al.
Publicado: (2023)

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
por: Brückner, Lea, et al.
Publicado: (2021)

Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020)

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020)

Use of Argatroban in Donor Lung Procurement: A Case Report
por: Sharif, Limi, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Ex vivo anticoagulants affect human blood platelet biomechanics with implications for high-throughput functional mechanophenotyping
por: Sachs, Laura, et al.
Publicado: (2022)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Author Correction: Ex vivo anticoagulants affect human blood platelet biomechanics with implications for high-throughput functional mechanophenotyping
por: Sachs, Laura, et al.
Publicado: (2022)

The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT
por: Koster, Andreas, et al.
Publicado: (2007)

Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis
por: Kim, Se-Chan, et al.
Publicado: (2015)

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
por: Menk, Mario, et al.
Publicado: (2017)

Argatroban/azd-1222/dexamethasone: Thrombotic thrombocytopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing
por: Savola, Paula, et al.
Publicado: (2022)

Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia
por: Ryan, Christine E., et al.
Publicado: (2023)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis
por: Yokota, Yuya, et al.
Publicado: (2019)

Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients
por: Liu, Shoufeng, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021)

Argatroban/immunostimulants: Vaccine-induced immune thrombotic thrombopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kq3ivd8l91rjubs4297vr67pfk